TheodoreWillisLaetschJr.MD

Pediatric Hematology & Oncology • Philadelphia, PA

Pediatric Hematologic Oncology, Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Associate Professor

Overview of Dr. Laetsch

Dr. Theodore Laetsch is a pediatric hematologist/oncologist in Philadelphia, PA and is affiliated with Children's Hospital of Philadelphia. He received his medical degree from University of California (San Francisco) School of Medicine and has been in practice 12 years. Dr. Laetsch accepts several types of health insurance, listed below. He is one of 166 doctors at Children's Hospital of Philadelphia who specialize in Pediatric Hematology & Oncology. He has more than 100 publications and over 500 citings.

Office
3401 Civic Center Blvd
Philadelphia, PA 19104
Book by Phone+1(267) 500-9732

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2009 - 2012
University of ColoradoResidency, Pediatrics, 2005 - 2009
University of California San Francisco School of MedicineClass of 2005

Certifications & Licensure

FL State Medical License 2021 - Present
DE State Medical License 2022 - 2025
NJ State Medical License 2022 - 2025
TX State Medical License 2013 - 2025
MD State Medical License 2021 - 2024
NC State Medical License 2021 - 2024
PA State Medical License 2009 - 2024
VA State Medical License 2022 - 2024
NY State Medical License 2021 - 2023
CO State Medical License 2007 - 2009
American Board of Pediatrics Pediatric Hematology-Oncology
Join now to see all

Clinical Trials

A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors Start of enrollment: 2014 Jan 08
Terminated
Phase 2
Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma Start of enrollment: 2014 Aug 01
Completed
Phase 2
Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients Start of enrollment: 2015 Apr 08
Completed
Phase 2
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children Start of enrollment: 2015 Dec 16
Active, not recruiting
Phase 1, Phase 2
Targeted Therapy to Increase RAI Uptake in Metastatic DTC Start of enrollment: 2021 Jul 16
Recruiting
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

85 citations
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
Theodore W Laetsch, Shannon L Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt
Journal of Clinical Oncology. 2023-03-20
551 citations
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S. Hong, Steven G. DuBois, Shivaani Kummar, Anna F. Farago, Catherine M. Albert
The Lancet. Oncology. 2020-04-01
3217 citations
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner, S. Rives, Michael Boyer
The New England Journal of Medicine. 2018-01-31

Journal Articles

Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia
Michael W Boyer, Bruce L Levine, Carl H June, Theodore W Laetsch, Clinical Cancer Research

Lectures

Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphobl...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Case Study: Precision Medicine for Infantile FibrosarcomaMarch 16th, 2023
Cancer Passed from Mother to Child During Childbirth?January 26th, 2021
CAR-T Yields High Responses in ALL Across TrialsNovember 16th, 2020
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Humana ChoiceCare Network PPO
Multiplan PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment